NCT00598013View on ClinicalTrials.gov

Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Kidney TransplantationInsulin ResistanceAtherosclerosis
Interventions
DRUG

Pioglitazone

The pioglitazone treatment group received 30mg pioglitazone at 2 weeks after renal transplantation for 12 months.

Trial Locations (1)

120-752

Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT00598013 - Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes | Biotech Hunter | Biotech Hunter